Mebeverine decreases mass movements and stool frequency in lactulose- induced diarrhoea

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 6, 1998, Pages 583-588

  Washington, N ^a   Ridley, P ^a   Thomas, C ^a   Spiller, R C ^a   Watts, P J ^b   Wilson, C G ^c  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; INDIUM CHLORIDE IN 111; ION EXCHANGE RESIN; LACTULOSE; MEBEVERINE; PERTECHNETIC ACID TC 99M; POLACRILIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG CAPSULE; ENTERIC COATED TABLET; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; IRRITABLE COLON; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; COLON; CROSS-OVER STUDIES; DEFECATION; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRANSIT; HUMANS; LACTULOSE; MALE; PARASYMPATHOLYTICS; PHENETHYLAMINES;

EID: 0031811493     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00340.x     Document Type: Article

References (22)

1. Drossman DA, Thompson WG, Talley NJ, et al. Identification of subgroups of functional gastrointestinal disorders. Gastroenterol Int 1990; 3: 159-72.
2. Manning AP, Thompson WC, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4.
3. Tasman-Jones C. Mebeverine in patients with irritable colon syndrome. NZ Med J 1973; 77: 232-4.
4. Kruis W, Weinzierl M, Schussler P, Holl J. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome. Digestion 1986; 34: 196-201.
5. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critical appraisal. Gastroenterology 1988; 95: 232-41.
6. Den Hertog A, Van den Akker J. The action of mebeverine and metabolites on mammalian non-myelinated nerve libres. Eur J Pharmacol 1987; 139: 353-5.
7. Messios N, Shaker M, Berry JM. Oral mebeverine in barium enema preparation. Clin Radiol 1982; 33: 271-2.
8. Daly J, Bergin A, Sun WM, Read NW. Effect of food and anti-cholinergic drugs on the pattern of rectosigmoid contractions. Gut 1993; 54: 799-802.
9. Barrow L, Steed KP, Spiller RC, et al. Scintigraphic demonstration of lactulose-induced accelerated proximal colon transit. Gastroenterology 1992; 103: 1167-73.
10. Bolin TD, Davis AE, Duncombe VM. A prospective study of persistent diarrhoea. Aust NZ J Med 1982; 12: 22-6.
11. Hardy JG, Perkins AC. Validity of the geometric mean correction in the quantification of whole bowel transit. Nucl Med Commun 1985; 6: 217-24.
12. Washington N, Harris M, Mussellwhite A, Greaves JL, Wilson CG, Spiller RC. Viscous fibre delays oro-caexcal transit during lactulose induced diarrhoea, impact on transit through the assending colon. Gut (Suppl.) 1992: F277 (Abstract).
13. Bassotti G, Imbimbo BP, Betti C, Dozzini G, Morelli A. Impaired colonic motor response to eating in patients with slow-transit constipation. Am J Gastroenterol 1992; 87: 504-8.
14. Narducci F, Bassotti G, Gaburri M, Morelli A. Twenty four hour manometric recording of colonic motor activity in healthy man. Gut 1987; 28: 17-25.
15. Nanda R, James R, Smith H, Dudley CRK, Jewel DP. Food intolerance and the irritable bowel syndrome. Gut 1989; 30: 1099-104.
16. Jones VA, McLaughlan P, Shorthouse M, Workman E, Hunter JO. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982; ii: 1115-17.
17. Symons P, Jones MP, Kellow JE. Symptom provocation in irritable bowel syndrome. Effect of differing doses of fructose-sorbitol. Scand J Gastroenterol 1992; 27: 940-4.
18. Florent C, Flourie B, Lebiond A, et al. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 1985; 75: 608-13.
19. Vassallo M, Camilleri M, Phillips SF, et al. Transit through the proximal colon influences stool weight in irritable bowel syndrome. Gastroenterology 1992; 102: 102-8.
20. Hammer J, Phillips SF. Fluid loading of the human colon. Effects on segmental transit and stool composition. Gastroenterology 1993; 105: 988-98.
21. Hedben JM, Gilchrist PJ, Blackshaw PE, et al. Colonic distribution of daily dosed, radiolabelled resin: right sided reservoir and left sided conduit. Gut 1995; 37(Suppl. 2): A47 (Abstract).
22. Evans PR, Buk YT, Kellow JE. Mebeverine alters small-bowel motility in irritable bowel syndrome. Aliment Pharmacol Ther 1996; 10: 787-93.